Cutaneous EBV-positive γδ T-cell lymphoma vs. extranodal NK/T-cell lymphoma: A case report and literature review

Journal of Cutaneous Pathology

Volumn 40, Issue 3, 2013, Pages 310-316

  Yu, Wei Wen ^a   Hsieh, Pin Pen ^a,b   Chuang, Shih Sung ^c,d  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b Yuh Ing Junior College of Health Care and Management   (Taiwan)

^c CHI MEI MEDICAL CENTER   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

T cell; T cell lymphoma; Cutaneous lymphoma; Extranodal natural killer T cell lymphoma; Peripheral T cell lymphoma; Taiwan

Indexed keywords

EPSTEIN BARR VIRUS ENCODED RNA 1; EPSTEIN-BARR VIRUS ENCODED RNA 1; LYMPHOCYTE ANTIGEN RECEPTOR; TUMOR PROTEIN; VIRUS RNA;

ΓΔ T-CELL; ΓΔ T-CELL LYMPHOMA; AGED; CASE REPORT; CLASSIFICATION; CUTANEOUS T CELL LYMPHOMA; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; EXTRANODAL NATURAL KILLER/T-CELL LYMPHOMA; FEMALE; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; PATHOLOGY; PERIPHERAL T CELL LYMPHOMA; REVIEW; SKIN LYMPHOMA; SKIN TUMOR; TAIWAN; VIROLOGY; WORLD HEALTH ORGANIZATION;

ΓΔ T-CELL; ΓΔ T-CELL LYMPHOMA; CUTANEOUS LYMPHOMA; EXTRANODAL NATURAL KILLER/T-CELL LYMPHOMA; PERIPHERAL T-CELL LYMPHOMA; TAIWAN;

AGED; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOMA, T-CELL, CUTANEOUS; NEOPLASM PROTEINS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RNA, VIRAL; SKIN NEOPLASMS; WORLD HEALTH ORGANIZATION;

EID: 84893848744     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/cup.12066     Document Type: Review

References (22)

1. Gaulard P, Berti E, Willemze R, Jaffe ES. Primary cutaneous peripheral T-cell lymphoma, rare subtypes. In Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, eds. WHO classification of tumours of haemtopoietic and lymphoid tissues. Lyon: IARC, 2008; 302.
2. Toro JR, Beaty M, Sorbara L, et al. Gamma delta T-cell lymphoma of the skin: a clinical, microscopic, and molecular study. Arch Dermatol 2000; 136: 1024.
3. Garcia-Herrera A, Song JY, Chuang SS, et al. Nonhepatosplenic gammadelta T-cell lymphomas represent a spectrum of aggressive cytotoxic T-cell lymphomas with a mainly extranodal presentation. Am J Surg Pathol 2011; 35: 1214.
4. Chan JKC, Quintanilla-Martinez L, Ferry JA, Peh S-C. Extranodal NK/T-cell lymphoma, nasal type. In Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, eds. WHO classification of tumours of haemtopoietic and lymphoid tissues. Lyon: IARC, 2008; 285.
5. Pongpruttipan T, Sukpanichnant S, Assanasen T, et al. Extranodal NK/T-cell lymphoma, nasal type, includes cases of natural killer cell and alphabeta, gammadelta, and alphabeta/gammadelta T-cell origin: a comprehensive clinicopathologic and phenotypic study. Am J Surg Pathol 2012; 36: 481.
6. Kim YH, Willemze R, Pimpinelli N, et al. TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 2007; 110: 479.
7. Kuo SY, Liu H, Liao YL, et al. A parallel comparison of T-cell clonality assessment between an in-house PCR assay and the BIOMED-2 assay leading to an efficient and cost-effective strategy. J Clin Pathol 2011; 64: 536.
8. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105: 3768.
9. Arnulf B, Copie-Bergman C, Delfau-Larue MH, et al. Nonhepatosplenic gammadelta T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization. Blood 1998; 91: 1723.
10. Ohshima K, Suzumiya J, Sugihara M, et al. Clinical, immunohistochemical and phenotypic features of aggressive nodal cytotoxic lymphomas, including alpha/beta, gamma/delta T-cell and natural killer cell types. Virchows Arch 1999; 435: 92.
11. Ohshima K, Liu Q, Koga T, Suzumiya J, Kikuchi M. Classification of cell lineage and anatomical site, and prognosis of extranodalTcell lymphoma -natural killer cell, cytotoxic T lymphocyte, and non-NK/CTL types. Virchows Arch 2002; 440: 425.
12. Belhadj K, Reyes F, Farcet JP, et al. Hepatosplenic gamma delta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. Blood 2003; 102: 4261.
13. Schieke SM, Sharaf MA, Lerner A, Runger TM, Mahalingam M. Primary cutaneous CD56 positive lymphoma: a diagnostic conundrum in an unusual case of lymphoma. J Cutan Pathol 2012; 39: 540.
14. Lu D, Lin CN, Chuang SS, Hwang WS, Huang WT. T-cell and NK/T-cell lymphomas in southern Taiwan: a study of 72 cases in a single institute. Leuk Lymphoma 2004; 45: 923.
15. Au WY,WeisenburgerDD, Intragumtornchai T, et al. Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project. Blood 2009; 113: 3931.
16. Stokkermans-Dubois J, Jouary T, Vergier B, Delaunay MM, Taieb A. A case of primary cutaneous nasal type NK/T-cell lymphoma and review of the literature. Dermatology 2006; 213: 345.
17. Wang J, Geng SA, Su Z, et al. Rearranged T-cell receptor gene and positive Epstein-Barr virus-encoded nuclear RNA in an extranodal NK/T-cell lymphoma with cutaneous manifestation only: case study. Clin Exp Dermatol 2007; 32: 744.
18. Liao JB, Chuang SS, Chen HC, Tseng HH, Wang JS, Hsieh PP. Clinicopathologic analysis of cutaneous lymphoma in Taiwan: a high frequency of extranodal NK/T-cell lymphoma, nasal type, with an extremely poor prognosis. Arch Pathol Lab Med 2010; 134: 996.
19. Duncan LM, Kumar S. Chapter 40. Primary cutaneous T-cell lymphomas: rare subtypes. In Jaffe ES HN, Vardiman JW, Campo E, Arber DA, eds. Hematopathology. St. Louis: Saunders, 2011; 617.
20. Iqbal J, Weisenburger DD, Chowdhury A, et al. Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic gammadelta Tcell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro. Leukemia 2011; 25: 348.
21. Choi YL, Park JH, Namkung JH, et al. Extranodal NK/T-cell lymphoma with cutaneous involvement: 'nasal' vs. 'nasal-type' subgroups -A retrospective study of 18 patients. Br J Dermatol 2009; 160: 333.
22. Ahn HK, Suh C, Chuang SS, et al. Extranodal natural killer/T-cell lymphoma from skin or soft tissue: suggestion of treatment from multinational retrospective analysis. Ann Oncol 2012; 23: 2703.